These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29233639)

  • 21. Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer.
    Mehdi RF; Sheikh F; Khan R; Fawad B; Haq AU
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1289-1293. PubMed ID: 31031231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
    Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
    Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.
    Liu Y; Li L; Qi H; Gao Y; Liu S; Xu C
    PLoS One; 2013; 8(2):e54081. PubMed ID: 23405077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
    Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
    Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
    Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
    Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
    Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
    Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survivin gene promoter -31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian children.
    Radojevic-Skodric S; Basta-Jovanovic G; Brasanac D; Nikolic N; Bogdanovic L; Milicic B; Milasin J
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e310-4. PubMed ID: 22858571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Survivin rs9904341 and rs17878467 Polymorphisms On Risk of Preeclampsia in Iran.
    Salimi S; Zaki-Dizaji M; Shafiee A; Saravani M; Jafarabady K; Ghasemi M; Norozi M; Heidary Z
    Biochem Genet; 2024 Jun; 62(3):2134-2147. PubMed ID: 37864584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer.
    He JM; Pu YD; Wu YJ; Qin R; Zhang QJ; Sun YS; Zheng WW; Chen LP
    Genet Mol Res; 2014 Oct; 13(4):8925-31. PubMed ID: 25366783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association of
    Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
    In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer.
    Aynaci E; Coskunpinar E; Eren A; Kum O; Oltulu YM; Akkaya N; Turna A; Yaylim I; Yildiz P
    Genet Mol Res; 2013 Feb; 12(3):3975-82. PubMed ID: 23479154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.
    Wang N; Li Y; Zhou RM; Cui SJ; Cao SR; Huang X; Huo XR; Shan BE
    Mutagenesis; 2019 Dec; 34(4):307-313. PubMed ID: 31165868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
    Javid J; Mir R; Julka PK; Ray PC; Saxena A
    Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.
    Xu L; Zhou X; Xu L; Yin R
    Tumour Biol; 2014 Feb; 35(2):1661-9. PubMed ID: 24096544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.